Omega Diagnostics Group PLC - Regional Selective Assistance - Grant funding

Released: Friday 30th November 2012

Omega, the AIM listed medical diagnostics company focussed on allergy, food intolerance and infectious disease, announces that it has been awarded a Regional Selective Assistance ("RSA") grant of up to £150,000 from Scottish Enterprise.

The RSA grant has been awarded towards the project of scaling up manufacturing facilities for the Company's new CD4 test for monitoring HIV positive patients. The facility will be located at the Company's Headquarters in Alva, Central Scotland and the grant will be payable in three instalments dependent on the attainment of employment targets and capital expenditure.  The project is split into two phases; the first phase being conversion of a part of the existing premises to meet initial customer demand and a second phase to allow further scale up to meet future anticipated demand.  It is expected that a first instalment of £32,000 will be received in the current financial year.
Omega Diagnostics Group PLC                               Tel: 01259 763 030
Andrew Shepherd, Chief Executive                              
Kieron Harbinson, Group Finance Director    
Jag Grewal, Group Sales and Marketing 
Seymour Pierce Limited                                           Tel: 020 7107 8000
Mark Percy (Corporate Finance)
David Banks / Katie Ratner (Corporate Broking)
Walbrook PR Limited
Paul McManus                                                                Tel: 020 7933 8787
                                                                                       Mob: 07980 541 893
Information about RSA:
RSA is a discretionary grant scheme, administered by Scottish Enterprise, that encourages businesses to undertake investment that will directly result in the creation or safeguarding of jobs in Scotland. The amount offered is dependent on the size of business, location of the project and an assessment of how much is needed for a project go ahead.

View all News